190 related articles for article (PubMed ID: 36194310)
21. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
[TBL] [Abstract][Full Text] [Related]
22. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic Total Pelvic Exenteration for Locally Recurrent Rectal Cancer.
Akiyoshi T; Nagasaki T; Ueno M
Ann Surg Oncol; 2015 Nov; 22(12):3896. PubMed ID: 25752892
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic Posterior Pelvic Exenteration (Complete and Supralevator) for Locally Advanced Adenocarcinoma of the Rectum in Females: Surgical Technique and Short-Term Outcomes.
Pokharkar A; Bankar S; Rohila J; Jaiswal D; deSouza A; Saklani A
J Laparoendosc Adv Surg Tech A; 2020 May; 30(5):558-563. PubMed ID: 31794331
[No Abstract] [Full Text] [Related]
25. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
26. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
[TBL] [Abstract][Full Text] [Related]
27. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic versus open surgery for stage I rectal cancer: long-term oncologic outcomes.
Lee SD; Park SC; Park JW; Kim DY; Choi HS; Oh JH
World J Surg; 2013 Mar; 37(3):646-51. PubMed ID: 23188532
[TBL] [Abstract][Full Text] [Related]
29. Propensity Score-Matched Analysis of Laparoscopic versus Open Surgery for Non-Metastatic Rectal Cancer.
Sakolprakaikij K; Yolsuriyanwong K; Wangkulangkul P; Bwaloy P; Cheewatanakornkul S
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3967-3975. PubMed ID: 34967578
[TBL] [Abstract][Full Text] [Related]
30. Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.
Nishizaki D; Hida K; Sumii A; Okamura R; Sakai Y; Konishi T; Akiyoshi T; Maruyama S; Okajima M; Miyakura Y; Yamamoto S; Morita S; Watanabe M;
Dis Colon Rectum; 2022 Aug; 65(8):1005-1014. PubMed ID: 34775411
[TBL] [Abstract][Full Text] [Related]
31. Minimally invasive versus open multivisceral resection for rectal cancer clinically invading adjacent organs: a propensity score-matched analysis.
Abe S; Nozawa H; Sasaki K; Murono K; Emoto S; Yokoyama Y; Matsuzaki H; Nagai Y; Shinagawa T; Sonoda H; Ishihara S
Surg Endosc; 2024 Jun; 38(6):3263-3272. PubMed ID: 38658387
[TBL] [Abstract][Full Text] [Related]
32. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.
Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy comparison between laparoscopy and open surgery in the treatment of gastric gastrointestinal stromal tumors larger than 2 cm using multicenter propensity score matching method].
Wu X; Sun LD; Wang M; Zhang P; Yang ZL; Liang H; Tao KX; Cao H; Xu WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):888-895. PubMed ID: 32927514
[No Abstract] [Full Text] [Related]
34. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
35. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
[TBL] [Abstract][Full Text] [Related]
36. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
[TBL] [Abstract][Full Text] [Related]
38. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
39. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
[TBL] [Abstract][Full Text] [Related]
40. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
